Phosphorylation of UBE2J1 at serine residue S184 contributes towards infection and cellular syncytialization by Vesicular Stomatitis Virus

This study demonstrates that Vesicular Stomatitis Virus infection promotes the phosphorylation of UBE2J1 at serine residue S184, a modification that enhances both viral replication and cellular syncytialization, with soluble forms of the protein potentially playing an even more significant role in these processes.

The Gist

The Big Picture: A Viral Hijacker and a Cellular "Cleanup Crew"

Imagine your body's cells are like a busy, high-tech factory. Inside this factory, there is a specialized cleanup crew called UBE2J1. Their main job is to find broken or misfolded machinery (proteins) and throw them in the trash (the proteasome) so the factory doesn't get clogged up. This is a good thing for the cell; it keeps things running smoothly.

However, the Vesicular Stomatitis Virus (VSV) is a sneaky burglar that breaks into this factory. This paper discovered that the virus doesn't just break in; it actually hijacks the cleanup crew to help it steal the factory and spread to other buildings.

The Main Discovery: How the Virus Wins

The researchers found that when the virus infects a cell, it tricks the UBE2J1 cleanup crew into working overtime. Instead of just cleaning up trash, the crew starts helping the virus build more copies of itself and spread to neighboring cells.

Here are the three key ways this happens, explained with analogies:

1. The "Glue" Effect (Syncytialization)

Normally, cells are like individual houses with walls between them. But when VSV infects a group of cells, it uses a special "glue" (a viral protein called VSV-G) to smash the walls down, merging many houses into one giant, multi-room mansion. Scientists call these giant merged cells syncytia.

• The Finding: The researchers found that when the UBE2J1 cleanup crew is active, it acts like a super-glue accelerator. It makes the cells merge into these giant mansions much faster and bigger than usual.
• The Analogy: Imagine a construction crew (UBE2J1) that is supposed to fix broken bricks. Instead, they start helping the burglar (Virus) knock down the walls between houses so the burglar can move freely between them. The more active the crew is, the bigger the merged mansion becomes.

2. The "Switch" on the Crew's Shirt (Phosphorylation)

The UBE2J1 crew has a special "on/off switch" on its back, located at a specific spot called Serine 184 (S184).

• The Finding: When this switch is flipped "ON" (a process called phosphorylation), the crew becomes super-efficient at helping the virus. When the researchers broke the switch (by changing S184 to a non-working version), the virus couldn't get the crew to help it merge cells as effectively.
• The Analogy: Think of UBE2J1 as a remote-controlled drone. The virus has a remote that flips a switch on the drone's back. When the switch is flipped, the drone flies faster and helps the virus. If you cut the wire to the switch, the drone is stuck on the ground and can't help the virus spread.

3. The "Loose Cannon" Effect (The Truncated Protein)

Usually, UBE2J1 is anchored to the factory floor (the Endoplasmic Reticulum) so it stays in one place.

• The Finding: The researchers created a version of UBE2J1 that was cut short, so it couldn't be anchored to the floor. It floated freely around the cell like a loose cannon. Surprisingly, this floating version was the most helpful to the virus of all! It caused the biggest, most massive cell mergers.
• The Analogy: Imagine the cleanup crew is usually tied to a specific workbench. But if you cut their ropes, they can run around the whole factory, helping the burglar smash down walls in every room at once. The "loose" crew was actually more dangerous to the cell's security than the "tied-down" crew.

Why Does This Matter?

This study is important for a few reasons:

1. Understanding the Virus: It shows us exactly how VSV spreads so quickly. It's not just about the virus entering the cell; it's about the virus turning the cell's own maintenance staff against it.
2. The "Switch" is Key: Since the S184 switch is so important, scientists might be able to design drugs that jam that switch. If you can keep the switch "OFF," you might stop the virus from merging cells and spreading.
3. Other Viruses: Since this mechanism (using UBE2J1 to help spread) seems to work for other viruses too (like Dengue and SARS-CoV-2), understanding it here could help us fight those viruses as well.

The Bottom Line

The virus VSV is a master manipulator. It finds the cell's own "cleanup crew" (UBE2J1), flips a specific switch on them, and sometimes even frees them from their posts. Once hijacked, this crew helps the virus smash down the walls between cells, creating giant super-cells that allow the virus to replicate and spread like wildfire. By understanding these specific switches and positions, scientists hope to find new ways to lock the doors and stop the infection.

Technical Summary

1. Problem Statement

The ubiquitin-conjugating enzyme UBE2J1 (also known as Ubc6e) is a key component of the Endoplasmic Reticulum-Associated Degradation (ERAD) pathway, responsible for the ubiquitination and proteasomal degradation of misfolded proteins. While UBE2J1 is known to play a role in viral infections—often by degrading antiviral factors like IRF3 to suppress interferon responses—its specific regulatory mechanisms during infection remain poorly understood.

Specifically, it is unclear:

• How UBE2J1 influences the replication of Vesicular Stomatitis Virus (VSV), a model negative-sense RNA virus.
• Whether the phosphorylation of UBE2J1 at Serine 184 (S184), a site previously linked to stress responses and other viral infections (e.g., Avian Leukosis Virus), is critical for VSV pathogenesis.
• The relationship between UBE2J1 activity, viral replication, and syncytialization (the fusion of infected cells into multinucleated giant cells), a process driven by the VSV glycoprotein (VSV-G) that facilitates viral spread and immune evasion.

2. Methodology

The study utilized BHK21 cells (and HEK293T for specific validation) as the primary experimental model. The researchers employed a combination of molecular biology, virology, and cell biology techniques:

• Plasmid Construction:
  • Generated wild-type (WT) human UBE2J1.
  • Created catalytically inactive mutant (C91S) to test enzymatic dependence.
  • Created phospho-deficient mutant (S184A) to test the role of phosphorylation.
  • Created a truncated mutant ($\Delta$TM) lacking the C-terminal transmembrane domain (residues 288–318), resulting in a soluble, cytoplasmic form of the protein.
  • Used a plasmid expressing the VSV-G protein to induce syncytia in the absence of live virus.
• Virus Generation:
  • Constructed a recombinant VSV-GFP virus (expressing Green Fluorescent Protein) to allow for easy visualization and quantification of infectivity.
• Experimental Assays:
  • Plaque Assay: To quantify viral titers (PFU/mL) in supernatants from cells overexpressing various UBE2J1 variants.
  • Syncytia Formation Assay: Cells were co-transfected with VSV-G and UBE2J1 variants. At 48 hours post-transfection, cells were fixed, stained (H&E), and imaged.
  • Quantification: ImageJ software was used to measure the total fusion area and the size of individual syncytia (defined as cells with $\ge$3 nuclei).
  • Western Blotting: Used to verify protein expression and detect phosphorylation at S184 using specific antibodies (anti-His, anti-UBE2J1, and anti-pSer184).

3. Key Contributions

This study provides the first direct evidence linking UBE2J1 to VSV pathogenesis and syncytialization. Key contributions include:

• Establishing a Pro-Viral Role: Demonstrating that UBE2J1 overexpression significantly enhances VSV replication and viral titers.
• Mechanistic Insight into Syncytia: Showing that UBE2J1 drives the formation of larger syncytia, a critical step in VSV dissemination.
• Role of Phosphorylation: Identifying that phosphorylation at S184 is essential for UBE2J1's ability to promote syncytialization and viral infection.
• Unexpected Localization Finding: Revealing that a soluble, cytoplasmic form of UBE2J1 (lacking the ER anchor) is more potent at inducing syncytia and viral replication than the native ER-localized form.

4. Key Results

A. UBE2J1 Enhances VSV Replication

• BHK21 cells overexpressing WT UBE2J1 produced significantly higher viral titers (PFU/mL) compared to empty vector controls when infected with VSV-GFP.
• This enhancement was dependent on the catalytic activity of UBE2J1; the C91S mutant failed to increase viral titers.

B. UBE2J1 Promotes Syncytialization

• Co-expression of VSV-G and WT UBE2J1 resulted in a significant increase in the fusion area compared to VSV-G alone.
• Catalytic Dependence: The C91S mutant abolished this enhancement, confirming that the ubiquitin-conjugating activity is required.
• Phosphorylation Dependence: The S184A mutant (phospho-deficient) showed a significant reduction in fusion area compared to WT, indicating that phosphorylation at S184 is crucial for this effect.
• Surprising Localization Effect: The $\Delta$TM mutant (soluble cytoplasmic form) induced the largest increase in syncytial fusion area and individual syncytia size, surpassing even the effect of doubling the VSV-G plasmid dose. This suggests that cytoplasmic accumulation of UBE2J1 may be a potent driver of infection.

C. Correlation Between Syncytia and Infectivity

• The viral titers observed in infection assays perfectly mirrored the syncytia formation data:
  • WT and $\Delta$TM: High syncytia formation $\rightarrow$ High viral titers.
  • C91S and S184A: Low syncytia formation $\rightarrow$ Low viral titers (similar to controls).
• Western blot analysis showed that while VSV-G expression did not visibly alter the phosphorylation ratio of UBE2J1 in the short term, the presence of the phosphorylated form (S184) was functionally necessary for the pro-viral phenotype.

5. Significance and Implications

• Novel Viral Subversion Mechanism: The study suggests that VSV (and potentially other RNA viruses) may exploit the host's UBE2J1 machinery not just to degrade antiviral factors (like IRF3/IRF7), but specifically to facilitate cell-to-cell fusion (syncytia).
• Role of Soluble UBE2J1: The finding that the cytoplasmic $\Delta$TM form is the most potent driver of infection is significant. It implies that viruses encoding proteases (like Enterovirus 71, which cleaves UBE2J1) might intentionally cleave UBE2J1 to release a soluble, hyper-active form that accelerates syncytialization and viral spread.
• Therapeutic Target: The specific requirement for S184 phosphorylation and the catalytic cysteine (C91) highlights potential targets for antiviral drugs. Inhibiting UBE2J1 phosphorylation or its catalytic activity could potentially disrupt the syncytialization process and limit viral propagation.
• Broader Context: These findings bridge the gap between ER stress response pathways and viral pathogenesis, suggesting that the regulation of UBE2J1 localization and post-translational modification is a critical node in viral infection cycles.

In conclusion, the paper demonstrates that UBE2J1 is a critical host factor for VSV, where its catalytic activity and S184 phosphorylation drive syncytialization, and its soluble cytoplasmic form represents a highly efficient mechanism for promoting viral infection.